242 related articles for article (PubMed ID: 33783978)
1. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases.
Xu Z; Li H; Yu X; Luo J; Zhang Z
Hematology; 2024 Dec; 29(1):2340144. PubMed ID: 38606818
[TBL] [Abstract][Full Text] [Related]
4. Treatment-related hemophagocytic lymphohistiocytosis due to atezolizumab: a case report and review of the literature.
Rubio-Perez J; Rodríguez-Perez ÁR; Díaz-Blázquez M; Moreno-García V; Dómine-Gómez M
J Med Case Rep; 2022 Oct; 16(1):365. PubMed ID: 36195892
[TBL] [Abstract][Full Text] [Related]
5. Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.
Dupré A; Michot JM; Schoeffler A; Frumholtz L; Baroudjian B; Delyon J; Lebbe C; Lambotte O
Br J Haematol; 2020 Jun; 189(5):985-992. PubMed ID: 32243578
[No Abstract] [Full Text] [Related]
6. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
Wang C; Sun W; Li Z; Wu T; Fang W
Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review.
Geusens D; Dierickx D; Carton S; Van Cutsem E; Dekervel J
Clin Colorectal Cancer; 2024 Jun; 23(2):194-197. PubMed ID: 38519390
[No Abstract] [Full Text] [Related]
10. Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer.
Okawa S; Kayatani H; Fujiwara K; Ozeki T; Takada K; Iwamoto Y; Minami D; Sato K; Shibayama T
Intern Med; 2019; 58(5):699-702. PubMed ID: 30828042
[TBL] [Abstract][Full Text] [Related]
11. First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors.
Azari AE; Stratton R; Singh A
Rheumatology (Oxford); 2021 May; 60(5):e167-e168. PubMed ID: 33280022
[No Abstract] [Full Text] [Related]
12. Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma.
Sasaki K; Uehara J; Iinuma S; Doi H; Honma M; Toki Y; Ishida-Yamamoto A
Ann Oncol; 2018 Jul; 29(7):1602-1603. PubMed ID: 29741568
[No Abstract] [Full Text] [Related]
13. Pembrolizumab associated hemophagocytic lymphohistiocytosis.
Shah D; Shrestha R; Ramlal R; Hatton J; Saeed H
Ann Oncol; 2017 Jun; 28(6):1403. PubMed ID: 28368439
[No Abstract] [Full Text] [Related]
14. Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir BC; Latifyan S; Perreau M; Fenwick C; Alberio L; Waeber G; Spertini F; de Leval L; Michielin O; Obeid M
Ann Oncol; 2020 Dec; 31(12):1775-1778. PubMed ID: 32858151
[No Abstract] [Full Text] [Related]
15. Hemophagocytic lymphohistiocytosis induced by nivolumab/ipilimumab combination therapy: A case of lung adenocarcinoma that responded to early steroid pulse therapy.
Hagiwara S; Tanizaki J; Hayashi H; Komeda Y; Nishida N; Yoshida A; Yamamoto T; Matsubara T; Kudo M
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1960. PubMed ID: 38196303
[TBL] [Abstract][Full Text] [Related]
16. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
[TBL] [Abstract][Full Text] [Related]
17. Rare and fatal complication of immune checkpoint inhibition: a case report of haemophagocytic lymphohistiocytosis with severe lichenoid dermatitis.
Choi S; Zhou M; Bahrani E; Martin BA; Ganjoo KN; Zaba LC
Br J Haematol; 2021 Jun; 193(6):e44-e47. PubMed ID: 33954981
[No Abstract] [Full Text] [Related]
18. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Hemophagocytic Lymphohistiocytosis Criteria and HScore in Critically Ill Patients With Severe Hemophagocytic Syndrome.
Valade S; Monseau G; Mariotte E; Darmon M
Crit Care Med; 2021 Sep; 49(9):e874-e879. PubMed ID: 33852445
[TBL] [Abstract][Full Text] [Related]
20. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
